Skip to main content
. 2017 Sep 27;8(51):88835–88844. doi: 10.18632/oncotarget.21340

Figure 1. Comparation of baseline NLR and PLR values in pancreatic cancer group with the ones in healthy subjects.

Figure 1

(A) Comparation of baseline NLR values in pancreatic cancer group with the ones in healthy subjects. Baseline NLR level was significantly higher in pancreatic cancer patients than in the healthy subjects (P<0.001). (B) Comparation of baseline PLR values in pancreatic cancer group with the ones in healthy subjects. Baseline PLR level was significantly higher in pancreatic cancer patients comparing with the healthy subjects (P<0.001).